![Oral amoxicillin as effective as injectable benzylpenicillin-gentamicin for infants with infection in which referral not possible [AFRINEST Trial]](https://www.2minutemedicine.com/wp-content/uploads/2015/04/NOVAMOXIN_antibiotic-350x250.jpg)
Seven days of antibiotic treatment non-inferior to 14 days for bloodstream infections
1. In this randomized controlled trial, among hospitalized patients with a bloodstream infection, seven days of antibiotic treatment was found...
Pharma
Short sleep duration associated with increased risk of diabetes
1. Short sleep duration (<6 hours per day) and regular or occasional snoring were associated with a higher risk of...
Trastuzumab emtansine improves outcomes in residual HER2-positive breast cancer
1. In this randomized controlled trial, adjuvant trastuzumab emtansine (T-DM1) reduced invasive disease events in patients with residual human epidermal...
Vertex: non-opioid pain reliever Journavx shows success in post operative pain control
In two randomized clinical trials evaluating pain control following abdominoplasty and bunionectomy, Journavx demonstrated statistically significant reductions in acute surgical...
Ponsegromab improves boy weight in cancer-related cachexia
1. Ponsegromab significantly increased body weight in patients with cancer cachexia and elevated GDF-15 levels compared to placebo at 12...
Levothyroxine supplementation in pregnancy not linked to prematurity risk
1. Levothyroxine usage for hypothyroidism in pregnancy was not linked to elevated prematurity risk Evidence Rating Level: 2 (Good) While...
Glucagon-like peptide-1 receptor agonists associated with lower depression risk in older adults with diabetes
1. In this target trial emulation, glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a lower risk of depression compared...
![RSV positivity associated with reduced serious bacterial infection risk [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/09/800px-Respiratory_syncytial_virus_01-350x250.jpg)
Shionogi and UBE: Novel Antiviral Drug Demonstrates Efficacy in RSV Patients
RSV patients treated with antiviral drug S-337395 showed statistically significant reduction in viral load S-337395 is generally safe and well...
De-escalating dual antiplatelet therapy may lower major bleeding risk following drug-eluting stent implantation
1. In this systematic review and meta-analysis, de-escalating dual antiplatelet therapy to ticagrelor monotherapy following implantation of a drug-eluting stent...
Bristol Myers Squibb: Opdivo-Qvantig is the first FDA approved subcutaneous version of cancer immunotherapy targeting PD-1
Opdivo-Qvantig had a non-inferior objective response rate compared to intravenous formulation in patients with locally advanced or metastatic clear cell...